Associate Director
Voyager Therapeutics, Massachusetts, United States
Sam Hasson is currently an Associate Director at Voyager Therapeutics (Cambridge, Massachusetts). A major aim of his work is to develop novel applications of AAV-based gene therapy in the CNS to transform the treatment of unmet medical needs. Prior to joining Voyager in 2020, Sam led groups within Amgen Neuroscience and Pfizer Neuroscience with a focus on the deconvolution of human disease genetics for drug target selection, employing genome editing technologies to enable this process. As a postdoc, Sam trained with Richard Youle and Jim Inglese at the National Institutes of Health.
Disclosure information not submitted.
Saturday, February 5, 2022
1:00 PM – 4:30 PM